Bg pattern

GLUCOSAMINE KORHISPANA 1500 mg ORAL SOLUTION POWDER

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use GLUCOSAMINE KORHISPANA 1500 mg ORAL SOLUTION POWDER

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

PACKAGE LEAFLET: INFORMATION FOR THE USER

GLUCOSAMINE KORHISPANA 1500 mg powder for oral solution EFG

Glucosamine sulfate

Read the entire leaflet carefully before starting to take the medicine.

  • Keep this leaflet, as you may need to read it again.
  • If you have any doubts, consult your doctor or pharmacist.
  • This medicine has been prescribed to you and should not be given to others, even if they have the same symptoms, as it may harm them.
  • If you consider that any of the side effects you are suffering from is serious or if you notice any side effect not mentioned in this leaflet, inform your doctor or pharmacist.

Contents of the package leaflet:

  1. What is Glucosamine Korhispana and what is it used for
  2. Before taking Glucosamine Korhispana
  3. How to take Glucosamine Korhispana
  4. Possible side effects
  5. Storage of Glucosamine Korhispana
  6. Additional information

1. What is Glucosamine Korhispana and what is it used for

Glucosamine Korhispana belongs to the group of medicines called other anti-inflammatory and non-steroidal anti-rheumatic compounds.

Glucosamine Korhispana is indicated to relieve the symptoms produced by mild to moderate knee osteoarthritis.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Before taking Glucosamine Korhispana

Do not take Glucosamine Korhispana:

  • If you are allergic (hypersensitive) to glucosamine or any of the other components of Glucosamine Korhispana.
  • If you are allergic (hypersensitive) to shellfish, since glucosamine is obtained from shellfish.

Be careful with Glucosamine Korhispana:

  • If you have altered sugar (glucose) tolerance. More frequent controls of blood sugar levels may be necessary when starting treatment with glucosamine.
  • If you have any risk factor for suffering from heart or artery diseases, since in some cases increases in cholesterol have been observed in patients treated with glucosamine.
  • If you have asthma. When starting treatment with glucosamine, you should consider that symptoms may worsen.
  • If you have any kidney or liver disorder, since no investigations have been carried out in these conditions and, therefore, no dosage recommendations can be given.

You should consult your doctor to rule out the presence of other joint diseases for which another treatment should be considered.

Do not take Glucosamine Korhispana if you are under 18 years old.

Use of other medicines:

Tell your doctor or pharmacist if you are using or have recently used other medicines, including those obtained without a prescription.

Be careful if you take Glucosamine Korhispana at the same time as other medicines, especially with warfarin and tetracycline. Consult your doctor for proper advice.

Some types of medicines used to prevent blood clotting (e.g., warfarin, dicumarol, phenprocoumon, acenocoumarol, and fluindione). The effect of these medicines may be enhanced if used together with glucosamine. Therefore, patients treated with these combinations should be monitored more closely when starting or stopping treatment with glucosamine.

Taking Glucosamine Korhispana with food and drinks:

Dissolve the contents of the Glucosamine Korhispana sachet in a glass of water and take it once a day, preferably with meals.

Pregnancy and breastfeeding:

Glucosamine Korhispana should not be used during pregnancy.

The use of glucosamine is not recommended during breastfeeding.

Consult your doctor or pharmacist before using any medicine.

Driving and using machines:

No studies have been conducted on how Glucosamine Korhispana affects the ability to drive and use machines. However, if you experience dizziness or drowsiness when taking Glucosamine Korhispana, you should not drive or operate machines (see section 4 "Possible side effects").

Important information about some of the components of Glucosamine Korhispana:

Patients with low-sodium diets should note that this medicine contains 151 mg (6.57 mmol) of sodium per sachet.

This medicine contains sorbitol. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking/using this medicine.

This medicine may be harmful to people with phenylketonuria because it contains aspartame, which is a source of phenylalanine.

3. How to take Glucosamine Korhispana

Follow exactly the administration instructions of Glucosamine Korhispana indicated by your doctor. Consult your doctor or pharmacist if you have doubts.

Your doctor will adjust the dose according to your condition.

Method of administration and dosage:

The normal starting dose is one sachet (dissolved in a glass of water) once a day, preferably with meals.

For oral use.

Duration of treatment:

Glucosamine is not indicated for the treatment of acute painful symptoms. Relief of symptoms (especially pain relief) may not occur until after several weeks of treatment, and in some cases even longer. If you do not experience relief from symptoms after 2-3 months, you should reconsider continuing treatment with glucosamine.

If you take more Glucosamine Korhispana than you should:

If you take more Glucosamine Korhispana than you should, or if another person or child takes this medicine, tell your doctor or pharmacist.

Signs and symptoms of overdose with glucosamine include headache, dizziness, confusion, joint pain, nausea, vomiting, diarrhea, or constipation. Do not continue taking Glucosamine Korhispana if you experience any of the symptoms mentioned above.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service. Telephone: (91) 562-04-20, indicating the medicine and the amount taken.

If you forget to take Glucosamine Korhispana:

Do not take a double dose to make up for forgotten doses.

If you have any other doubts about the use of this product, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, Glucosamine Korhispana can cause side effects, although not everyone gets them.

You should interrupt the treatment of glucosamine and go immediately to your doctor if you experience symptoms of angioedema, such as:

  • Swelling of the face, tongue, or throat
  • Difficulty swallowing.
  • Urticaria and difficulty breathing.

The most frequently observed are:

Frequent (affecting 1 to 10 out of every 100 people)

  • Headache.
  • Fatigue.
  • Nausea.
  • Abdominal pain.
  • Indigestion.
  • Diarrhea.
  • Constipation.

Uncommon (affecting 1 to 10 out of every 1,000 people)

  • Rash
  • Itching.
  • Redness
  • Vomiting.

Frequency not known (cannot be estimated from the available data)

  • Dizziness.
  • Worsening of asthma symptoms.
  • Swelling in the ankles, legs, and feet.
  • Urticaria.
  • Increase in cholesterol levels and worsening of blood sugar (glucose) levels in patients with diabetes mellitus.

If you consider that any of the side effects you are suffering from is serious or if you notice any side effect not mentioned in this leaflet, inform your doctor or pharmacist.

5. Storage of Glucosamine Korhispana

This medicine does not require special storage conditions.

Keep out of the reach and sight of children.

Do not use Glucosamine Korhispana after the expiration date stated on the sachet and packaging after the abbreviation CAD. The expiration date is the last day of the month indicated.

Medicines should not be disposed of through wastewater or household waste. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

6. Additional information

Composition of Glucosamine Korhispana:

The active ingredient is glucosamine. Each Glucosamine Korhispana sachet contains 1,500 mg of glucosamine sulfate as glucosamine sulfate sodium chloride, equivalent to 1,178 mg of glucosamine.

The other components are: aspartame (E951), sorbitol (E420), sodium, citric acid, and macrogol 4000

Appearance of the product and packaging content:

Glucosamine Korhispana is presented in single-dose sachets containing powder for oral solution. Each package contains 20 or 30 sachets.

Marketing authorization holder and manufacturer:

Holder:

Korhispana, S.L.

Carretera de Castellvell, 24

43206 REUS (Tarragona)

Manufacturer:

LABORATORIOS SERRA PAMIES, S.A.

Carretera de Castellvell, 24

43206 REUS (Tarragona)

This leaflet was revised in November 2021

Online doctors for GLUCOSAMINE KORHISPANA 1500 mg ORAL SOLUTION POWDER

Discuss questions about GLUCOSAMINE KORHISPANA 1500 mg ORAL SOLUTION POWDER, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for GLUCOSAMINE KORHISPANA 1500 mg ORAL SOLUTION POWDER?
GLUCOSAMINE KORHISPANA 1500 mg ORAL SOLUTION POWDER requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in GLUCOSAMINE KORHISPANA 1500 mg ORAL SOLUTION POWDER?
The active ingredient in GLUCOSAMINE KORHISPANA 1500 mg ORAL SOLUTION POWDER is glucosamine. This information helps identify medicines with the same composition but different brand names.
How much does GLUCOSAMINE KORHISPANA 1500 mg ORAL SOLUTION POWDER cost in pharmacies?
The average pharmacy price for GLUCOSAMINE KORHISPANA 1500 mg ORAL SOLUTION POWDER is around 6.14 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures GLUCOSAMINE KORHISPANA 1500 mg ORAL SOLUTION POWDER?
GLUCOSAMINE KORHISPANA 1500 mg ORAL SOLUTION POWDER is manufactured by Korhispana S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of GLUCOSAMINE KORHISPANA 1500 mg ORAL SOLUTION POWDER online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether GLUCOSAMINE KORHISPANA 1500 mg ORAL SOLUTION POWDER is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to GLUCOSAMINE KORHISPANA 1500 mg ORAL SOLUTION POWDER?
Other medicines with the same active substance (glucosamine) include ACENAM 1250 mg EFFERVSCENT TABLETS, CARTISORB 1500 mg POWDER FOR ORAL SOLUTION, DUARTRON 625 mg HARD CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media